Literature DB >> 23646875

Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology.

Artak Tovmasyan1, Tin Weitner, Huaxin Sheng, MiaoMiao Lu, Zrinka Rajic, David S Warner, Ivan Spasojevic, Julio S Reboucas, Ludmil Benov, Ines Batinic-Haberle.   

Abstract

The different biological behavior of cationic Fe and Mn pyridylporphyrins in Escherichia coli and mouse studies prompted us to revisit and compare their chemistry. For that purpose, the series of ortho and meta isomers of Fe(III) meso-tetrakis-N-alkylpyridylporphyrins, alkyl being methyl to n-octyl, were synthesized and characterized by elemental analysis, UV/vis spectroscopy, mass spectrometry, lipophilicity, protonation equilibria of axial waters, metal-centered reduction potential, E(1/2) for M(III)P/M(II)P redox couple (M = Fe, Mn, P = porphyrin), kcat for the catalysis of O2(•-) dismutation, stability toward peroxide-driven porphyrin oxidative degradation (produced in the catalysis of ascorbate oxidation by MP), ability to affect growth of SOD-deficient E. coli, and toxicity to mice. Electron-deficiency of the metal site is modulated by the porphyrin ligand, which renders Fe(III) porphyrins ≥5 orders of magnitude more acidic than the analogous Mn(III) porphyrins, as revealed by the pKa1 of axially coordinated waters. The 5 log units difference in the acidity between the Mn and Fe sites in porphyrin translates into the predominance of tetracationic (OH)(H2O)FeP complexes relative to pentacationic (H2O)2MnP species at pH ∼7.8. This is additionally evidenced in large differences in the E(1/2) values of M(III)P/M(II)P redox couples. The presence of hydroxo ligand labilizes trans-axial water which results in higher reactivity of Fe relative to Mn center. The differences in the catalysis of O2(•-) dismutation (log kcat) between Fe and Mn porphyrins is modest, 2.5-5-fold, due to predominantly outer-sphere, with partial inner-sphere character of two reaction steps. However, the rate constant for the inner-sphere H2O2-based porphyrin oxidative degradation is 18-fold larger for (OH)(H2O)FeP than for (H2O)2MnP. The in vivo consequences of the differences between the Fe and Mn porphyrins were best demonstrated in SOD-deficient E. coli growth. On the basis of fairly similar log kcat(O2(•-)) values, a very similar effect on the growth of SOD-deficient E. coli was anticipated by both metalloporphyrins. Yet, while (H2O)2MnTE-2-PyP(5+) was fully efficacious at ≥20 μM, the Fe analogue (OH)(H2O)FeTE-2-PyP(4+) supported SOD-deficient E. coli growth at as much as 200-fold lower doses in the range of 0.1-1 μM. Moreover the pattern of SOD-deficient E. coli growth was different with Mn and Fe porphyrins. Such results suggested a different mode of action of these metalloporphyrins. Further exploration demonstrated that (1) 0.1 μM (OH)(H2O)FeTE-2-PyP(4+) provided similar growth stimulation as the 0.1 μM Fe salt, while the 20 μM Mn salt provides no protection to E. coli; and (2) 1 μM Fe porphyrin is fully degraded by 12 h in E. coli cytosol and growth medium, while Mn porphyrin is not. Stimulation of the aerobic growth of SOD-deficient E. coli by the Fe porphyrin is therefore due to iron acquisition. Our data suggest that in vivo, redox-driven degradation of Fe porphyrins resulting in Fe release plays a major role in their biological action. Possibly, iron reconstitutes enzymes bearing [4Fe-4S] clusters as active sites. Under the same experimental conditions, (OH)(H2O)FePs do not cause mouse arterial hypotension, whereas (H2O)2MnPs do, which greatly limits the application of Mn porphyrins in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23646875      PMCID: PMC3731146          DOI: 10.1021/ic3012519

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  63 in total

1.  Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes.

Authors:  Júlio S Rebouças; Ivan Spasojević; Ines Batinić-Haberle
Journal:  J Pharm Biomed Anal       Date:  2008-08-14       Impact factor: 3.935

2.  Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst.

Authors:  Csaba Szabó; Jon G Mabley; Suzanne M Moeller; Roman Shimanovich; Pál Pacher; László Virag; Francisco G Soriano; John H Van Duzer; William Williams; Andrew L Salzman; John T Groves
Journal:  Mol Med       Date:  2002-10       Impact factor: 6.354

3.  Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.

Authors:  Xiaodong Ye; Diane Fels; Artak Tovmasyan; Katherine M Aird; Casey Dedeugd; Jennifer L Allensworth; Ivan Kos; Won Park; Ivan Spasojevic; Gayathri R Devi; Mark W Dewhirst; Kam W Leong; Ines Batinic-Haberle
Journal:  Free Radic Res       Date:  2011-09-27

4.  Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants.

Authors:  Galen M Pieper; Vani Nilakantan; Min Chen; Jing Zhou; Ashwani K Khanna; James D Henderson; Christopher P Johnson; Allan M Roza; Csaba Szabó
Journal:  J Pharmacol Exp Ther       Date:  2005-03-22       Impact factor: 4.030

5.  A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.

Authors:  Zrinka Rajic; Artak Tovmasyan; Ivan Spasojevic; Huaxin Sheng; Miaomiao Lu; Alice M Li; Edith B Gralla; David S Warner; Ludmil Benov; Ines Batinic-Haberle
Journal:  Free Radic Biol Med       Date:  2012-02-13       Impact factor: 7.376

6.  Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants.

Authors:  G Ferrer-Sueta; I Batinić-Haberle; I Spasojević; I Fridovich; R Radi
Journal:  Chem Res Toxicol       Date:  1999-05       Impact factor: 3.739

7.  Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier.

Authors:  Júlio S Rebouças; Gilson DeFreitas-Silva; Ivan Spasojević; Ynara M Idemori; Ludmil Benov; Ines Batinić-Haberle
Journal:  Free Radic Biol Med       Date:  2008-05-05       Impact factor: 7.376

Review 8.  High-valent iron in chemical and biological oxidations.

Authors:  John T Groves
Journal:  J Inorg Biochem       Date:  2006-03-03       Impact factor: 4.155

9.  Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins.

Authors:  Ivan Kos; Júlio S Rebouças; Gilson DeFreitas-Silva; Daniela Salvemini; Zeljko Vujaskovic; Mark W Dewhirst; Ivan Spasojević; Ines Batinić-Haberle
Journal:  Free Radic Biol Med       Date:  2009-04-08       Impact factor: 7.376

Review 10.  Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators.

Authors:  Artak Tovmasyan; Huaxin Sheng; Tin Weitner; Amanda Arulpragasam; Miaomiao Lu; David S Warner; Zeljko Vujaskovic; Ivan Spasojevic; Ines Batinic-Haberle
Journal:  Med Princ Pract       Date:  2012-10-16       Impact factor: 1.927

View more
  19 in total

1.  Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death.

Authors:  Myron K Evans; Artak Tovmasyan; Ines Batinic-Haberle; Gayathri R Devi
Journal:  Free Radic Biol Med       Date:  2013-12-12       Impact factor: 7.376

2.  Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP5+, and its alkoxyalkyl analogues.

Authors:  Zrinka Rajic; Artak Tovmasyan; Otávio L de Santana; Isabelle N Peixoto; Ivan Spasojevic; Silmar A do Monte; Elizete Ventura; Júlio S Rebouças; Ines Batinic-Haberle
Journal:  J Inorg Biochem       Date:  2017-01-05       Impact factor: 4.155

Review 3.  Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2018-08-28       Impact factor: 8.401

4.  A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeutics.

Authors:  Artak Tovmasyan; Clarissa G C Maia; Tin Weitner; Sebastián Carballal; Romulo S Sampaio; Dominik Lieb; Robert Ghazaryan; Ivana Ivanovic-Burmazovic; Gerardo Ferrer-Sueta; Rafael Radi; Julio S Reboucas; Ivan Spasojevic; Ludmil Benov; Ines Batinic-Haberle
Journal:  Free Radic Biol Med       Date:  2015-05-28       Impact factor: 7.376

5.  Photodynamic antimicrobial activity of new porphyrin derivatives against methicillin resistant Staphylococcus aureus.

Authors:  Hüseyin Taslı; Ayse Akbıyık; Nermin Topaloğlu; Vildan Alptüzün; Sülünay Parlar
Journal:  J Microbiol       Date:  2018-10-24       Impact factor: 3.422

6.  Novel amphiphilic cationic porphyrin and its Ag(II) complex as potential anticancer agents.

Authors:  Artak Tovmasyan; Nelli Babayan; David Poghosyan; Kristine Margaryan; Boris Harutyunyan; Rusanna Grigoryan; Natalia Sarkisyan; Ivan Spasojevic; Suren Mamyan; Lida Sahakyan; Rouben Aroutiounian; Robert Ghazaryan; Gennadi Gasparyan
Journal:  J Inorg Biochem       Date:  2014-06-27       Impact factor: 4.155

Review 7.  Simple biological systems for assessing the activity of superoxide dismutase mimics.

Authors:  Artak Tovmasyan; Julio S Reboucas; Ludmil Benov
Journal:  Antioxid Redox Signal       Date:  2013-10-19       Impact factor: 8.401

Review 8.  SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Emily R H Roberts; Zeljko Vujaskovic; Kam W Leong; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2013-10-01       Impact factor: 8.401

9.  Acid-base and electrochemical properties of manganese meso(ortho- and meta-N-ethylpyridyl)porphyrins: voltammetric and chronocoulometric study of protolytic and redox equilibria.

Authors:  Tin Weitner; Ivan Kos; Zoran Mandić; Ines Batinić-Haberle; Mladen Biruš
Journal:  Dalton Trans       Date:  2013-10-01       Impact factor: 4.390

10.  Anticancer therapeutic potential of Mn porphyrin/ascorbate system.

Authors:  Artak Tovmasyan; Romulo S Sampaio; Mary-Keara Boss; Jacqueline C Bueno-Janice; Bader H Bader; Milini Thomas; Julio S Reboucas; Michael Orr; Joshua D Chandler; Young-Mi Go; Dean P Jones; Talaignair N Venkatraman; Sinisa Haberle; Natalia Kyui; Christopher D Lascola; Mark W Dewhirst; Ivan Spasojevic; Ludmil Benov; Ines Batinic-Haberle
Journal:  Free Radic Biol Med       Date:  2015-10-20       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.